Cardinal Health will achieve $10 billion in adjusted free cash flow over the next three years. It has already increased its ...

Abbott partners with MSD to distribute anti-diabetic medicines in India; Zydus receives FDA observations; Welcure secures ...

Here are four action items to mitigate the effect of LLM security vulnerabilities on the pharmaceutical industry and its ...

Citius Pharmaceuticals Inc (NASDAQ: CTXR ), the parent company of Citius Oncology, also saw its shares climb by 6.7%. Meanwhile, Cardinal Health’s stock remained flat after the news.

Under the terms of the agreement, SUP will be responsible for obtaining the necessary regulatory approvals to sell Tiotropium ...

Abbott and MSD Pharmaceuticals announced a distribution pact for oral anti-diabetic medicines like Januvia, Janumet, and ...

Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...